Business
Rapid testing no substitute to COVID vaccination: Cochlear boss – Sydney Morning Herald
The $17 billion hearing implants maker has returned to profit, with its boss focused on emerging from the pandemic with a stronger…
The $17 billion hearing implants maker posted record sales of $1.4 billion for the 12 months to June and managed to spring from its $238 million loss in 2020 to a $327 million net profit for 2021.
The profit exceeded expectations, but overall sales came…
Continue Reading
-
General10 hours agoEmergency services winch man to safety in Great Ocean Road cliff rescue
-
Business20 hours agoTop brokers name 3 ASX shares to buy next week 1 June 2025
-
General14 hours agoSocceroos name 26-man squad for World Cup qualifier against Japan in Perth
-
Noosa News22 hours agoBiodiversity at Bowra | Noosa Today